Answers are grounded in this paper and cite their sources.
Preclinical animal study demonstrates that mesenchymal stem cell exosomes restore fine motor function after cortical injury in monkeys, suggesting potential for post-stroke recovery therapies.
BACKGROUND: Exosomes from mesenchymal stromal cells (MSCs) are endosome-derived vesicles that have been shown to enhance functional recovery in rodent models of stroke. OBJECTIVE: Building on these findings, we tested exosomes as a treatment in monkeys with cortical injury. METHODS: After being trained on a task of fine motor function of the hand, monkeys received a cortical injury to the hand representation in primary motor cortex. Twenty-four hours later and again 14 days after injury, monkeys received exosomes or vehicle control. Recovery of motor function was followed for 12 weeks. RESULTS: Compared to monkeys that received vehicle, exosome treated monkeys returned to pre-operative grasp patterns and latency to retrieve a food reward in the first three-five weeks of recovery. CONCLUSIONS: These results provide evidence that in monkeys exosomes delivered after cortical injury enhance recovery of motor function.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: